268 related articles for article (PubMed ID: 29796114)
21. Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Chidharla A; Rapoport E; Agarwal K; Madala S; Linares B; Sun W; Chakrabarti S; Kasi A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373376
[TBL] [Abstract][Full Text] [Related]
22. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of methylated branched chain amino acid transaminase 1/IKAROS family zinc finger 1 for colorectal cancer.
Xu K; Yu AR; Pan SB; He J
World J Gastroenterol; 2023 Sep; 29(36):5240-5253. PubMed ID: 37901447
[TBL] [Abstract][Full Text] [Related]
24. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
25. Tumour-agnostic circulating tumour DNA analysis for improved recurrence surveillance after resection of colorectal liver metastases: A prospective cohort study.
Øgaard N; Reinert T; Henriksen TV; Frydendahl A; Aagaard E; Ørntoft MW; Larsen MØ; Knudsen AR; Mortensen FV; Andersen CL
Eur J Cancer; 2022 Mar; 163():163-176. PubMed ID: 35074652
[TBL] [Abstract][Full Text] [Related]
26. Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation.
Mo S; Ye L; Wang D; Han L; Zhou S; Wang H; Dai W; Wang Y; Luo W; Wang R; Xu Y; Cai S; Liu R; Wang Z; Cai G
JAMA Oncol; 2023 Jun; 9(6):770-778. PubMed ID: 37079312
[TBL] [Abstract][Full Text] [Related]
27. Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis.
Jones RP; Pugh SA; Graham J; Primrose JN; Barriuso J
Eur J Cancer; 2021 Feb; 144():368-381. PubMed ID: 33422803
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer detected by liquid biopsy 2 years prior to clinical diagnosis in the HUNT study.
Brenne SS; Madsen PH; Pedersen IS; Hveem K; Skorpen F; Krarup HB; Giskeødegård GF; Laugsand EA
Br J Cancer; 2023 Sep; 129(5):861-868. PubMed ID: 37438612
[TBL] [Abstract][Full Text] [Related]
29. Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational study.
Kang G; Chen K; Yang F; Chuai S; Zhao H; Zhang K; Li B; Zhang Z; Wang J
BMC Cancer; 2019 Jun; 19(1):579. PubMed ID: 31195991
[TBL] [Abstract][Full Text] [Related]
30. A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia.
Symonds EL; Pedersen SK; Baker RT; Murray DH; Gaur S; Cole SR; Gopalsamy G; Mangira D; LaPointe LC; Young GP
Clin Transl Gastroenterol; 2016 Jan; 7(1):e137. PubMed ID: 26765125
[TBL] [Abstract][Full Text] [Related]
31. Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer.
Luo H; Zhao Q; Wei W; Zheng L; Yi S; Li G; Wang W; Sheng H; Pu H; Mo H; Zuo Z; Liu Z; Li C; Xie C; Zeng Z; Li W; Hao X; Liu Y; Cao S; Liu W; Gibson S; Zhang K; Xu G; Xu RH
Sci Transl Med; 2020 Jan; 12(524):. PubMed ID: 31894106
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies.
Tie J; Cohen JD; Lo SN; Wang Y; Li L; Christie M; Lee M; Wong R; Kosmider S; Skinner I; Wong HL; Lee B; Burge ME; Yip D; Karapetis CS; Price TJ; Tebbutt NC; Haydon AM; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Popoli M; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
Int J Cancer; 2021 Feb; 148(4):1014-1026. PubMed ID: 32984952
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer.
Mitchell SM; Ho T; Brown GS; Baker RT; Thomas ML; McEvoy A; Xu ZZ; Ross JP; Lockett TJ; Young GP; LaPointe LC; Pedersen SK; Molloy PL
Genes (Basel); 2016 Dec; 7(12):. PubMed ID: 27983717
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a Multi-Gene Methylation Blood-Test for the Detection of Colorectal Cancer.
Petit J; Carroll G; Williams H; Pockney P; Scott RJ
Med Sci (Basel); 2023 Sep; 11(3):. PubMed ID: 37755164
[TBL] [Abstract][Full Text] [Related]
35. Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.
Narayan RR; Goldman DA; Gonen M; Reichel J; Huberman KH; Raj S; Viale A; Kemeny NE; Allen PJ; Balachandran VP; D'Angelica MI; DeMatteo RP; Drebin JA; Jarnagin WR; Kingham TP
Ann Surg Oncol; 2019 Jun; 26(6):1824-1832. PubMed ID: 30706231
[TBL] [Abstract][Full Text] [Related]
36. Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction.
Nassar FJ; Msheik ZS; Nasr RR; Temraz SN
Clin Epigenetics; 2021 May; 13(1):111. PubMed ID: 34001239
[TBL] [Abstract][Full Text] [Related]
37. Low Sensitivity of Fecal Immunochemical Tests and Blood-Based Markers of DNA Hypermethylation for Detection of Sessile Serrated Adenomas/Polyps.
Cock C; Anwar S; Byrne SE; Meng R; Pedersen S; Fraser RJL; Young GP; Symonds EL
Dig Dis Sci; 2019 Sep; 64(9):2555-2562. PubMed ID: 30835026
[TBL] [Abstract][Full Text] [Related]
38. Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA.
Benešová L; Hálková T; Ptáčková R; Semyakina A; Menclová K; Pudil J; Ryska M; Levý M; Šimša J; Pazdírek F; Hoch J; Blaha M; Minárik M
World J Gastroenterol; 2019 Dec; 25(48):6939-6948. PubMed ID: 31908397
[TBL] [Abstract][Full Text] [Related]
39. Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study.
Schraa SJ; van Rooijen KL; van der Kruijssen DEW; Rubio Alarcón C; Phallen J; Sausen M; Simmons J; Coupé VMH; van Grevenstein WMU; Elias S; Verkooijen HM; Laclé MM; Bosch LJW; van den Broek D; Meijer GA; Velculescu VE; Fijneman RJA; Vink GR; Koopman M;
BMC Cancer; 2020 Aug; 20(1):790. PubMed ID: 32819390
[TBL] [Abstract][Full Text] [Related]
40. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
